Earnings playbook: The reporting season kicks off with big banks and Netflix on deck

The second-quarter earnings season is underway with muted expectations, as S&P 500 earnings are projected to grow just 4.8% year-over-year, marking the lowest rate since Q4 2023, amid an evolving tariff landscape. Major banks, including JPMorgan Chase, Wells Fargo, and Goldman Sachs, will be closely watched for net interest income trends, expense management, and trading revenue, with potential impacts from Federal Reserve rate cuts. Additionally, Johnson & Johnson faces concerns over threatened pharmaceutical tariffs, while streaming giant Netflix is anticipated to report robust earnings growth, with investor focus on its ad-tier and subscriber trends.

Analysis

The second-quarter earnings season commences with muted overall expectations, as FactSet projects S&P 500 earnings growth of just 4.8% year-over-year, the lowest rate since Q4 2023, primarily attributed to an uncertain tariff environment. The banking sector presents a divergent outlook: JPMorgan faces expectations of a sharp earnings decrease and potential headwinds from Fed rate cuts, while Wells Fargo contends with a recent downgrade and flat revenue forecasts, suggesting its recovery may be priced in. In contrast, Morgan Stanley and Goldman Sachs are poised for growth above 6% and 10% respectively, driven by strong trading and wealth management, although their significant year-to-date stock gains of over 23% set a high bar for performance. Beyond banking, Johnson & Johnson confronts a significant idiosyncratic risk from a potential 200% pharmaceutical tariff, which overshadows its projected 5% earnings decline despite its long history of beating estimates. Netflix stands out as a key growth story, with analysts anticipating a 45% surge in year-over-year earnings, shifting investor focus to the sustainability of subscriber growth and the performance of its ad-supported tier.

Key Decisions for Investors

• Given the mixed outlook for banks, investors should closely scrutinize management commentary on expense controls and net interest income guidance, as these will be key differentiators for performance amid potential Fed rate cuts.
• For Johnson & Johnson, any commentary on the threatened 200% pharmaceutical tariff is a critical catalyst that could introduce significant volatility, potentially outweighing the reported earnings figures.
• While Netflix is expected to report strong 45% earnings growth, focus should be on forward-looking metrics such as subscriber trends and ad-tier monetization to justify its high valuation and growth expectations.
• With shares of Citigroup and Goldman Sachs already up 23% year-to-date, these stocks require exceptionally strong results and optimistic guidance to sustain their momentum, posing a risk of a 'sell the news' reaction if they only meet expectations.